You are here

Michel Revel

Prof. Michel Revel
12.09.2010

 A drug developed  by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.

Prof. Michel Revel
08.09.2010

Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...

Prof. Michel Revel
09.09.2006
Prof. Michel Revel was elected a member of the Israel Academy of Sciences and Humanities.
Four graduates of the Weizmann Institute's feinberg graduate School, who today form the senior staff of Pharmos. Left to rigth: Dr. Michael Schickler, Prof. Haim Aviv, Dr. Cynthia Webb, and Dr. Vered Lavie
01.05.2001

Prof. Haim Aviv is starting his sixth bio-tech company

The Benefits of Immaturity
01.10.1999
A method developed in Institute labs could keep stem cells "fresh" for longer
New Molecule Boosts Stem Cell Survival
01.08.1999
Weizmann Institute researchers have developed a molecule that allows blood stem cells - the body's most primitive, immature...
Rebif Spells Relief
01.10.1997

Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness